Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Clearmind Medicine Inc’s stock clocked out at $1.19, down -2.46% from its previous closing price of $1.22. In other words, the price has decreased by -$2.46 from its previous closing price. On the day, 1.0 million shares were traded. CMND stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.13.
Ratios:
To gain a deeper understanding of CMND’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMND now has a Market Capitalization of 3881244 and an Enterprise Value of -5299339.
Stock Price History:
The Beta on a monthly basis for CMND is -1.73, which has changed by -0.9375328 over the last 52 weeks, in comparison to a change of 0.2160933 over the same period for the S&P500. Over the past 52 weeks, CMND has reached a high of $24.67, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is -13.69%, while the 200-Day Moving Average is calculated to be -78.18%.
Shares Statistics:
It appears that CMND traded 760.19K shares on average per day over the past three months and 277020 shares per day over the past ten days. A total of 3.17M shares are outstanding, with a floating share count of 2.92M. Insiders hold about 7.75% of the company’s shares, while institutions hold 7.38% stake in the company. Shares short for CMND as of 1711584000 were 178784 with a Short Ratio of 0.24, compared to 1709164800 on 230660. Therefore, it implies a Short% of Shares Outstanding of 178784 and a Short% of Float of 5.4899998.
Earnings Estimates
The performance of Clearmind Medicine Inc (CMND) in the stock market is under the watchful eye of — analysts actively contributing to its current rating.The consensus estimate for the next quarter is –$, with high estimates of –$ and low estimates of –$.
Analysts are recommending an EPS of between –$ and –$ for the fiscal current year, implying an average EPS of –$. EPS for the following year is –$, with — analysts recommending between –$ and –$.
